New bisindole alkaloids isolated from myxomycetes arcyria cinerea and lycogala epidendrum

Chemical and Pharmaceutical Bulletin

Volumn 53, Issue 5, 2005, Pages 594-597

  Kamata, Kazuaki ^a   Kiyota, Makiko ^a   Naoe, Ayano ^a   Nakatani, Satomi ^a   Yamamoto, Yukinori ^b   Hayashi, Masahiko ^c   Komiyama, Kanki ^c   Yamori, Takao ^d   Ishibashi, Masami ^a  

^a CHIBA UNIVERSITY   (Japan)

^b Kitasato Institute ^*  (Japan)

^c KITASATO INSTITUTE   (Japan)

^d CANCER CHEMOTHERAPY CENTER   (Japan)

Author keywords

Arcyria cinerea; Bisindole; Cytotoxicity; Lycogala epidendrum; Myxomycetes

Indexed keywords

ARCYRIAFLAVIN A; ARCYRIAFLAVIN B; BISINDOLE ALKALOID; CINEREAPYRROLE A; CINEREAPYRROLE B; INDOLE ALKALOID; LYCOGARIC ACID A; LYCOGARUBIN B; LYCOGARUBIN C; STAUROSPORINONE; UNCLASSIFIED DRUG;

ARCYRIA CINEREA; ARTICLE; CANCER CELL CULTURE; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; HELA CELL; HUMAN; HUMAN CELL; LYCOGALA EPIDENDRUM; MYXOMYCETES; PROTON NUCLEAR MAGNETIC RESONANCE;

ANIMALS; CYTOTOXINS; DICTYOSTELIIDA; HELA CELLS; HUMANS; INDOLE ALKALOIDS; MYXOMYCETES;

EID: 19644376013     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.53.594     Document Type: Article

References (12)

1. Steglich W., Pure Appl. Chem., 61, 281-288 (1989).
2. Nakatani S., Yamamoto Y., Hayashi M., Komiyama K., Ishibashi M., Chem. Pharm. Bull., 52, 368-370 (2004).
3. Kamata K., Onuki H., Hirota H., Yamamoto Y., Hayashi M., Komiyama K., Sato M., Ishibashi M., Tetrahedron, 60, 9835-9839 (2004).
4. Nakatani S., Kamata K., Sato M., Onuki H., Hirota H., Matsumoto J., Ishibashi M., Tetrahedron Lett., 46, 267-271 (2005).
5. Steglich W., Steffan B., Kopanski L., Eckhardt G., Angew. Chem. Int. Ed. Engl., 19, 459-460 (1980).
6. Fröde R., Hinze C., Josten I., Schmidt B., Steffan B., Steglich W., Tetrahedron Lett., 35, 1689-1690 (1994).
7. Hashimoto T., Yasuda A., Akazawa K., Takaoka S., Tori M., Asakawa Y., Tetrahedron Lett., 35, 2559-2560 (1994).
8. Yasuzawa T., Iida T., Yoshida M., Hirayama N., Takahashi M., Shirahata K., Sano H., J. Antibiot., 39, 1072-1078 (1986).
9. Yamori T., Matsunaga A., Sato S., Yamazaki K., Komi A., Ishizu K., Mita I., Edatsugi H., Matsuba Y., Takezawa K., Nakanishi O., Kohno H., Nakajima Y., Komatsu H., Andoh T., Tsuruo T., Cancer Res., 59, 4042-4049 (1999).
10. Larsson R., Kristensen J., Sandberg C., Nygren P., Int. J. Cancer, 50, 177-185 (1992).
11. Hayashi M., Koike K., Rho M.-C., Kuwano M., Kishie T., Komiyama K., Anti-Cancer Drug Des., 16, 255-260 (2001).
12. Alley M. C., Scudiero D. A., Monks A., Hursey M. L., Czerwinski M. J., Fine D. L., Abbott B. J., Mayo J. G., Shoemaker R. H., Boyd M. R., Cancer Res., 48, 589-601 (1998).